Home CombiMatrix Corp (CBMX) Receives "Buy" Rating from Zacks Investment Research
 

Keywords :   


CombiMatrix Corp (CBMX) Receives "Buy" Rating from Zacks Investment Research

2016-02-21 21:23:01| Biotech - Topix.net

's stock had its "buy" rating reissued by Zacks Investment Research in a research note issued on Sunday, MarketBeat Ratings reports. They currently have a $20.00 price target on the stock.

Tags: buy research rating investment

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
28.11 HEXAGON TR SET UP
28.1121dc hg
28.111EX D
28.11 Bucchus IMP24 FMH-RSM/M
28.11
28.11specialites TA carmina 46-36
28.11HUNTER×HUNTER
28.11
More »